Prince William has sent his "congratulations" to his close friend, Kevin Sinfield, as the rugby union coach raises money and ...
USCIS proposes cutting fees for the controversial EB-5 visa program despite years of fraud, security warnings, and high ...
The audio version of this article is generated by AI-based technology. Mispronunciations can occur. We are working with our partners to continually review and improve the results. An emotional Jeremy ...
Capricor Therapeutics reported positive data from its phase three study of its Deramiocel therapy to treat Duchenne muscular dystrophy. The company said the study met the primary endpoint and the key ...
Capricor Therapeutics Inc. (NASDAQ: CAPR) stock is rallying on Wednesday. The company shared much-awaited topline results from its pivotal Phase 3 HOPE-3 trial evaluating Deramiocel, the company’s ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 multiple ascending dose (MAD) clinical study of SRP-1003 ...
PHOENIX — Jace Taylor is a rambunctious 4-year-old boy. He runs, jumps and plays with his friends. He isn’t aware that genetically, he’s different from other children. “I think he’s too young to ...
CAMBRIDGE, Mass., November 24, 2025--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 ...
Novartis’ Itvisma (onasemnogene) has been approved by the US FDA to treat spinal muscular atrophy (SMA) in children aged two years and older, teenagers and adults with a confirmed mutation in the ...
Treatment for mycobacterium avium complex (MAC) depends on where the infection is. Your doctor will also consider how serious your symptoms are and other medical conditions you may have. Here’s what ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sarepta Therapeutics, Inc. (SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 multiple ascending dose (MAD) ...